NEW YORK (Reuters) - Ads for Pfizer Inc.'s Celebrex arthritis drug are set to splash across U.S. television screens on Monday after more than a two-year hiatus, with an unusual upfront focus on its ...

A new DTC print ad for Pfizer’s Celebrex has become a target of criticism for Congress and the consumer group Public Citizen. Full-color ads that first appeared last week in US magazines feature an ...

Just one week after Pfizer launched a new television ad for its pain killer Celebrex, consumer group Public Citizen has come out attacking the spot, calling on the FDA to order Pfizer to stop airing ...

A watchdog group that is often critical of drug advertising is calling on the FDA to ban Pfizer's new Celebrex ad (pictured at left; watch it here), which the group calls "dangerous" and "misleading." ...

Pfizer is on the hot seat after a consumer group accused the pharmaceutical giant of playing down the safety risks of Celebrex in a new spot. The world's biggest drugmaker began running TV ads for ...

Advertisements for the arthritis drug Celebrex were misleading and unsubstantiated, overstating the pain reliever’s benefits and understating the risks, the government said Wednesday. Subscribe to ...

WASHINGTON (MarketWatch) -- The consumer advocacy group Public Citizen is calling on the U.S. Food and Drug Administration to order Pfizer Inc. PFE, +0.42% to withdraw its new television commercial ...

CHICAGO, April 9 (Reuters) - A consumer group accused Pfizer Inc. on Monday of downplaying safety differences between its Celebrex medicine and other painkillers in a new advertisement and said U.S.

Pfizer recently released the first commercial in more than two years for Celebrex, an arthritis pain drug infamously associated with increased risks of heart attack and stroke. In 2004, the FDA urged ...

With mounting pressure from advocacy groups and Congress, drug companies are reconsidering their approach to advertisements. One major criticism is that the ads give short-shrift to a drug's risks and ...